- Home
- GH vs RIOT Comparison
GH vs RIOT Comparison
Compare GH & RIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- RIOT
- Stock Information
- Founded
- GH 2011
- RIOT 2000
- Country
- GH United States
- RIOT United States
- Employees
- GH N/A
- RIOT N/A
- Industry
- GH Medical Specialities
- RIOT Retail: Computer Software & Peripheral Equipment
- Sector
- GH Health Care
- RIOT Technology
- Exchange
- GH Nasdaq
- RIOT Nasdaq
- Market Cap
- GH 2.7B
- RIOT 2.4B
- IPO Year
- GH 2018
- RIOT N/A
- Fundamental
- Price
- GH $20.68
- RIOT $9.20
- Analyst Decision
- GH Strong Buy
- RIOT Strong Buy
- Analyst Count
- GH 16
- RIOT 11
- Target Price
- GH $39.67
- RIOT $16.96
- AVG Volume (30 Days)
- GH 1.6M
- RIOT 19.4M
- Earning Date
- GH 11-06-2024
- RIOT 10-30-2024
- Dividend Yield
- GH N/A
- RIOT N/A
- EPS Growth
- GH N/A
- RIOT N/A
- EPS
- GH N/A
- RIOT 0.40
- Revenue
- GH $643,810,000.00
- RIOT $280,017,000.00
- Revenue This Year
- GH $27.01
- RIOT $40.84
- Revenue Next Year
- GH $18.30
- RIOT $80.62
- P/E Ratio
- GH N/A
- RIOT $23.19
- Revenue Growth
- GH 26.20
- RIOT 9.21
- 52 Week Low
- GH $15.81
- RIOT $6.36
- 52 Week High
- GH $37.04
- RIOT $18.75
- Technical
- Relative Strength Index (RSI)
- GH 33.92
- RIOT 69.01
- Support Level
- GH $20.36
- RIOT $7.61
- Resistance Level
- GH $21.95
- RIOT $9.13
- Average True Range (ATR)
- GH 0.74
- RIOT 0.44
- MACD
- GH 0.11
- RIOT 0.19
- Stochastic Oscillator
- GH 16.56
- RIOT 89.52
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.